Loading organizations...
§ Private Profile · Tel Aviv, Israel
Clinical AI software company providing real-time medical imaging analysis to detect acute conditions for healthcare providers, focused on radiology.
Aidoc has raised $494.0M across 8 funding rounds.
Key people at Aidoc.
Aidoc has raised $494.0M in total across 8 funding rounds.
Based in Tel Aviv, Aidoc develops artificial intelligence software that analyzes medical imaging, such as CT scans and X-rays, to detect acute abnormalities and automatically flag critical conditions for radiologists in real-time. The enterprise software-as-a-service platform holds 17 FDA clearances and is currently deployed across more than 1,000 medical centers worldwide, supporting clinical workflows and care for over 45 million patients annually. The company licenses its specialized clinical triage algorithms to major healthcare providers and hospital networks, including Mount Sinai Health System, Yale New Haven Health System, and Mayo Clinic. To support its ongoing expansion into cardiology and oncology, Aidoc has raised $370 million in total venture capital funding from institutional backers such as General Catalyst and Nvidia's venture arm. The healthcare technology company was founded in 2016 by Elad Walach, Michael Braginsky, and Guy Reiner.
Aidoc is an Israeli-founded technology company specializing in clinical AI solutions for healthcare, primarily focusing on AI-powered medical imaging analysis to detect acute conditions from CT scans and streamline workflows.[1][2][4] Its core product is the aiOS™ platform, an enterprise operating system that integrates FDA-cleared AI algorithms, supports real-time monitoring, and enables seamless hospital system interoperability, serving over 45 million patients annually across 1,200+ medical centers and 150+ health systems worldwide, including top U.S. hospitals like Mount Sinai and Yale New Haven.[1][3][5] Aidoc targets radiologists, cardiologists, neurologists, and care teams, solving critical problems like diagnostic delays, fragmented workflows, and preventable care gaps by prioritizing urgent findings and activating teams for faster interventions, which improves patient outcomes and operational efficiency.[2][4][6] With $370M in total funding, including a recent $150M round, Aidoc reports $95M revenue and plans to expand to 100 million patients in three years via its CARE foundation model.[1][3][6]
Founded in 2016 in Israel, Aidoc began by commercializing a single AI product for radiologists to detect critical conditions on CT scans, evolving rapidly into a comprehensive platform analyzing 20+ conditions across 900+ global hospitals.[1][5] Key leadership includes CEO Elad Walach, who drives the mission to reduce diagnostic errors and empower physicians.[3][6] Early traction came from FDA clearances—now at 18, the most in clinical AI—and deployments in seven of the top ten U.S. hospitals, building on partnerships with NVIDIA and AWS for scalable AI development.[1][3][5] Pivotal moments include shifting from point solutions to a multisided aiOS™ ecosystem hosting partner algorithms and the 2025 $150M funding for CARE, compressing years of roadmap into faster innovation for oncology and cardiovascular expansion.[3][6]
Aidoc rides the clinical AI wave in healthcare, addressing fragmented systems and diagnostic errors amid rising imaging volumes and staffing shortages, with timing amplified by post-pandemic demands for efficiency and AI regulatory progress (e.g., FDA clearances).[1][4][5] Market forces like high-performance computing from NVIDIA/AWS and foundation models like CARE favor Aidoc, enabling scalable, "always-on" intelligence that unifies silos across specialties.[3][6] It influences the ecosystem by pioneering hospital-centric platforms, fostering multi-vendor AI adoption (BRIDGE guidelines with NVIDIA), and partnering with 150+ systems to set standards for accountable AI deployment, accelerating broader healthcare transformation.[1][6]
Aidoc is poised to dominate clinical AI with CARE expanding to 90% disease coverage and 100M patients in three years, prioritizing oncology and cardiovascular while growing its open aiOS™ ecosystem.[3][6] Trends like multimodal AI, real-time inference, and regulatory maturity will propel it, potentially evolving from radiology-focused to a full-spectrum care platform influencing global standards. As AI becomes foundational to every patient encounter, Aidoc's trajectory reinforces its role as a pioneer, transforming reactive healthcare into proactive, outcome-driven systems.[3][6]
Key people at Aidoc.
Aidoc has raised $494.0M in total across 8 funding rounds.
Aidoc's investors include General Catalyst, Alpha Intelligence Capital, Bond, Khosla Ventures, LGF, Sapphire Ventures, Square Peg Capital, TCV, TLV Partners, Transformation Capital, Danny Hadar, Uday Sandhu.
Aidoc has raised $494.0M across 8 funding rounds. Most recently, it raised $150.0M Other Equity in July 2025.
